Mengqi Guo

机构：Qingdao University, Affiliated Hospital of Qingdao University · ORCID：0000-0001-7770-5832

发表论文 46 篇 · 总被引 1906 次 · h-index 18

代表论文

• A novel approach for relapsed/refractory FLT3mut+ acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib (2022 · Molecular Cancer · 被引 49)
• A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis (2022 · Pharmacological Research · 被引 39)
• Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway (2022 · International Immunopharmacology · 被引 24)
• A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes (2024 · Diabetologia · 被引 18)
• The TFPI2–PPARγ axis induces M2 polarization and inhibits fibroblast activation to promote recovery from post-myocardial infarction in diabetic mice (2023 · Journal of Inflammation · 被引 16)
• Macrophage‐mediated heart repair and remodeling: A promising therapeutic target for post‐myocardial infarction heart failure (2024 · Journal of Cellular Physiology · 被引 13)